Ref: Høydahl et al. BMC Cancer (2022) 22:975,  https://doi.org/10.1186/s12885-022-10058-9 Background: The number of older patients with rectal cancer is increasing. Treatment outcome discrepancies persist, despite similar treatment guidelines. To offer the oldest patients optimal individually adjusted care, further knowledge is needed regarding treatment strategy and outcome. The present study aimed

Ref: Choi S. etal., Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials, Investig Clin Urol. 2022 Mar;63(2):140-150. Doi: 10.4111/icu.20210340. Introduction Several studies have been conducted to evaluate reducing the recurrence and progression of non-muscle-invasive bladder cancer (NMIBC). Intravesical Bacille Calmette-Guérin (BCG) instillation

Ref: Zheng S.,etal., Elsevier , Volume 100, December 2022, Pages 254-261, https://doi.org/10.1016/j.sleep.2022.08.014 Purpose Whether preexisting sleep disorder is an independent risk factor for cancer remains unclear. Therefore, we performed this propensity score–matched population-based cohort study to compare the incidence rate ratios (IRRs) of specific cancers between patients with and without sleep disorders. Patients

Bao X. etal., Diabetologia (2022) 65:1642–1651, https://doi.org/10.1007/s00125-022-05771-w Aims/hypothesis Diabetes is associated with an increased risk of cancer. Prostasin is an epithelial sodium channel stimulator that has been associated with suppression of tumours, glucose metabolism and hyperglycaemia-associated tumour pathology. However, the association between prostasin, diabetes and cancer mortality has not been